Dermata Therapeutics (DRMA) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-4.5
-3.45
-2.39
-1.34

Details

Expected EPS
-4.5
Actual EPS
-4.5
Surprise EPS
0
Surprise Percent
+0%

Description

Dermata Therapeutics (DRMA) has reported earnings of -4.5 per share for Q2 2025.

0 Comments

Share your thoughts